Latest Information Update: 28 Mar 2008
At a glance
- Originator EPIX Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 28 May 2003 No development reported - Preclinical for Magnetic resonance imaging in USA (unspecified route)
- 29 Mar 2000 Preclinical development for Magnetic resonance imaging in USA (Unknown route)